Exfoliative esophagitis in a patient with metastatic renal cell carcinoma during sunitinib treatment

被引:4
作者
Huang, Jiwei [1 ]
Wang, Tianrong [2 ]
Huang, Yiran [1 ]
机构
[1] Shanghai Jiao Tong Univ Sch Med, Renji Hosp, Dept Urol, Shanghai 200127, Peoples R China
[2] Shanghai Jiao Tong Univ Sch Med, Renji Hosp, Dept Gastroenterol, Shanghai 200127, Peoples R China
关键词
ENDOTHELIAL GROWTH-FACTOR; EXPRESSION;
D O I
10.1007/s12032-012-0436-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 8 条
[1]   Esophageal ulceration triggers expression of hypoxia-inducible factor-1α and activates vascular endothelial growth factor gene -: Implications for angiogenesis and ulcer healing [J].
Baatar, D ;
Jones, MK ;
Tsugawa, K ;
Pai, R ;
Moon, WS ;
Koh, GY ;
Kim, I ;
Kitano, S ;
Tarnawski, AS .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04) :1449-1457
[2]   Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor receptor induction and extracellular signal-regulated kinase 2 activation [J].
Baatar, D ;
Jones, MK ;
Pai, R ;
Kawanaka, H ;
Szabo, IL ;
Moon, WS ;
Kitano, S ;
Tarnawski, AS .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (03) :963-972
[3]   A case of exfoliative esophagitis with pemphigus vulgaris [J].
Fukuchi, M. ;
Otake, S. ;
Naitoh, H. ;
Shoji, H. ;
Yamagishi, J. ;
Suzuki, M. ;
Yanoma, T. ;
Kuwano, H. .
DISEASES OF THE ESOPHAGUS, 2011, 24 (03) :E23-E25
[4]   Three Cases of Severe Ulcerative Esophagitis Induced by SUTENT® [J].
Odile Jeanniard-Malet ;
Gwenaëlle Gravis ;
Fabrice Caillol ;
Christian Pesenti ;
Erwan Bories ;
Marc Giovannini .
Journal of Gastrointestinal Cancer, 2012, 43 (1) :128-130
[5]   Growth factors expression in patients with erosive esophagitis [J].
Luo, Jiing-Chyuan ;
Lin, Hsiao-Yi ;
Lu, Ching-Liang ;
Chen, Tseng-Shing ;
Lin, Han-Chieh ;
Li, Chung-Pin ;
Liao, Wei-Chih ;
Chang, Full-Young ;
Lee, Shou-Dong .
TRANSLATIONAL RESEARCH, 2008, 152 (02) :81-87
[6]   Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib [J].
Porta, C. ;
Paglino, C. ;
Imarisio, I. ;
Bonomi, L. .
CLINICAL AND EXPERIMENTAL MEDICINE, 2007, 7 (04) :127-134
[7]  
van der Veldt AAM, 2010, DISCOV MED, V10, P394
[8]   Management of Vascular Endothelial Growth Factor and Multikinase Inhibitor Side Effects [J].
Wood, Laura S. .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2009, 13 (06) :13-18